Risk factor
Very high price volatility
Profitability factor
Very low or no dividends
About
RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes...
Company Valuation
Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers.
Target Price
The average target price of RXST is 10 and suggests 40% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increase
Buy
Sell